Clinical Development Clinical Trials Nurses 
XTalks
JUNE 4, 2024
In the ever-evolving landscape of pharmaceutical development, the complexity of early phase clinical trials is increasing. This surge in complexity is driven by escalating drug development costs, heightened competition and advanced scientific innovations. This is the storm that we find ourselves in the midst of.”
XTalks
NOVEMBER 19, 2021
Cardiac biomarkers can not only serve important roles in the diagnosis, management and prognosis of cardiac diseases, but they can also be significant tools in evaluating treatments in cardiovascular (CV) clinical trials. In CV clinical trials, cardiac biomarkers are most commonly included in efficacy and safety endpoints.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 19, 2021
A survey by rare disease patient network Raremark found that 86% of the community members asked were interested in taking part in clinical trials. CEO Jeremy Edwards looks at how decentralised trial models can solve some of the challenges for clinical trial recruitment in rare disease.
Worldwide Clinical Trials
JUNE 15, 2022
The pandemic has had a lasting impact on the ability of sites to participate in trials, particularly in the US. We’ve also seen a decrease in available research nurses, as they have had to be reassigned to COVID patients. 5 Things You Need to Know from Our Recent Gene Therapy Webinar appeared first on Worldwide Clinical Trials.
XTalks
OCTOBER 18, 2022
A clinical research organization (CRO) is a company that delivers outsourced services to plan, manage and execute clinical trials for biotechnology, pharmaceutical, and medical device companies. This has led to a sharp increase in the number of clinical trials ( Figure 1 ). Clinical trial management.
XTalks
FEBRUARY 10, 2023
According to a recent review published in Nature , as of April 2022 almost 1,800 active cell therapy clinical trials were listed in ClinicalTrials.gov, a 33 percent increase from 2021. In a recent webinar, Dr. Vassallo discussed the operational considerations for complex cell therapy clinical trials.
WCG Clinical
JULY 17, 2023
And now, I am in a role that I love at Genentech in their greed division, which is their early phase in early clinical development group for protocol and study management. So I’d say we saw an overall constraint applied in 2022 to sites and their ability to open trials. It’s a global position.
Expert insights. Personalized for you.
110 
Let's personalize your content